VI
GNMK

Versor Investments’s GenMark Diagnostics, Inc GNMK Stock Holding History

Versor Investments’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,664,831
Closed -$63.7M – 418
2021
Q1 		$63.7M Buy
+2,664,831
New +$49.5M 3.8% 13

Versor Investments's GNMK Position: Q2 2021 in Review

Versor Investments sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 2,664,831 shares — an estimated $63.7M sold.

Versor Investments first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $63.7M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Versor Investments reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Versor Investments sold 2,664,831 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $63.7M.
  • Versor Investments first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
  • Versor Investments's GenMark Diagnostics, Inc position peaked at $63.7M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Versor Investments's 13F filing for Q2 2021, filed 27 Jul 2021.